Generic Portal

— Research Explorer

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1186/s13063-022-06874-w
Final published version

Mieke van Schaik
Eline J. Arends
Darius Soonawala
Ellen van Ommen
Karina de Leeuw
Maarten Limper
Pieter van Paassen
Tom W. J. Huizinga
René E. M. Toes
Cees van Kooten
Joris I. Rotmans
Ton J. Rabelink
Y. K. Onno Teng

Original language	English
Article number	939
Journal	Trials
Volume	23
Issue number	1
DOIs	https://doi.org/10.1186/s13063-022-06874-w
Publication status	Published - 1 Dec 2022
Externally published	Yes

Research areas

Belimumab, Clinical trial, Lupus nephritis, Rituximab, Systemic autoimmune disease, Systemic lupus erythematosus

ID: 27519897